Zymeworks R&D head sells 13,832 shares to cover taxes
The EVP, Head of R&D's sale was confined to mandatory sell-to-cover provisions for required taxes and fees.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
On October 9, 2026, Zymeworks Inc. EVP, Head of R&D Adam Schayowitz had 37,037 restricted stock units vest, issuing 37,037 common shares. He sold 13,832 shares at a weighted average price of $25.85 per share to cover required taxes and fees under mandatory sell-to-cover provisions; the sale was not discretionary. His reported post-transaction balance was 74,074 RSUs.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F4, F5 | 37,037 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 37,037 | $0.00 | $0.00 |
| Sale | Common Stock F2, F3 | 13,832 | $25.85 | $358K |
Footnotes (5)
- F1. Represents shares of common stock issued upon vesting of one third of the restricted stock units ("RSUs") granted on October 9, 2025.
- F2. Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory "sell to cover" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
- F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.85 to $25.88, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F4. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of common stock.
- F5. Restricted stock units ("RSUs") granted October 9, 2025; vest in three equal annual installments beginning October 9, 2026.
Key Figures
Key Terms
Restricted stock units ("RSUs") financial
sell to cover financial
weighted average price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How did Adam Schayowitz's Zymeworks RSUs vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.